Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
Open accessThe DOI matches its Crossref record; 207 of the 209 references it cites were found in a registry or an index.
Abstract
Although continuous glucose monitoring (CGM) devices are now considered the standard of care for people with type 1 diabetes mellitus, the uptake among people with type 2 diabetes mellitus (T2DM) has been slower and is focused on those receiving intensive insulin therapy. However, increasing evidence now supports the inclusion of CGM in the routine care of people with T2DM who are on basal insulin-only regimens or are managed with other medications. Expanding CGM to these groups could minimize hypoglycaemia while allowing efficient adaptation and escalation of therapies. Increasing evidence from randomized controlled trials and observational studies indicates that CGM is of clinical value in people with T2DM on non-intensive treatment regimens. If further studies confirm this finding, CGM could soon become a part of routine care for T2DM. In this Perspective we explore the potential benefits of widening the application of CGM in T2DM, along with the challenges that must be overcome for the evidence-based benefits of this technology to be delivered for all people with T2DM.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ajjan et al. 54 and Fernando et al. 55 provide strong support for expanding CGM use in noninsulin‐treated adults living with T2DM, including a proposed framework for the use of CGM throughout the natural history of T2D.”
Citations
Cites
Items 201–207 of 207
Monnier, L., Colette, C., & Owens, D. R. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0006 · Cited by 8 · cited 1×
“…in T2DM and achieve a time below range in hypoglycaemia of 3.0 mmol/l (54 mg/dl) target of 1% of readings each day 40 , it is important that glycaemic variability, as measured by coefficient of variation over the observation period, remains 30% of the mean glucose concentration 39,41 .”
InfluentialRoussel, R., Detournay, B., Boultif, Z., Bahloul, A., Teissier, C., & Charbonnel, B. H. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00874-2 · Cited by 7 · cited 1×
“…and titration of basal insulin therapy can be associated with episodes of problematic hypoglycaemia, particularly in older people (who can be more frail) 129 , which is a common reason for discontinuation of this therapy or for reluctance of HCPs to adjust the basal insulin dose upwards 130,131 .”
Wu, C. C., Wu, K. C., José, A. S., & Novin, N. (2022) · JMIR Diabetes · doi:10.2196/30626 · Cited by 7 · cited 1×
“Telemedicine programmes delivered in primary care have also demonstrated improvements in HbA 1c , TIR and time below range compared with standard care 205 .”
Majjouti, K., Küppers, L., Thielmann, A., Redaèlli, M., Vitinius, F., Funke, C., van der Arend, I., Pilic, L., Heßbrügge, M., Stock, S., et al. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01827-3 · Cited by 6 · cited 1×
“The role of peer-to-peer support programmes for people with T2DM in partnership with primary care teams is another emerging opportunity, including peer-led education or lifestyle support meetings, with phone or web-based support 163 .”
Ajjan, R., Heller, S. R., Everett, C., Vargas‐Palacios, A., Higham, R., Sharples, L. D., Gorog, D. A., Rogers, A., Reynolds, C. B., Fernandez, C., et al. (2022) · doi:10.2337/figshare.21496824.v1 · Cited by 5
Self-citationMonnier, L., Colette, C., & Owens, D. R. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0286 · Cited by 1
Bahia, L., Mello, K. F., de Lemos, L. L. P., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3216250/v1 · Cited by 1
Cited by
Chen, Y., Yang, Z., Liu, Y., Gue, Y. X., Zhong, Z., Chen, T., Wang, F., McDowell, G., Huang, B., & Lip, G. Y. H. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02521-7 · Cited by 39
“Continuous glucose monitoring offers a more comprehensive approach, capturing real-time changes and providing better insight into glycemic variability [59].”
Layne, J. E., Jepson, L. H., Carite, A. M., Parkin, C. G., & Bergenstal, R. M. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0197 · Cited by 37
“19 As with glycemic targets, many patient factors may contribute to determining optimal CGM wear cadence and further research may support different recommendations based upon these factors.”
Wang, Y., Lu, J., Yu, J., Ni, J., Wang, M., Lu, W., Zhu, W. M., Guo, J., Bao, Y., & Zhou, J. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16143 · Cited by 32
Benhalima, K., Durnwald, C. P., Sweeting, A., Adams, D., Addala, A., Battelino, T., Bergenstal, R. M., Carlson, A. L., Donovan, L., Franco, D. R., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00335-3 · Cited by 37
Self-citationAlkabbani, W., CROMER, S. J., Kim, D. H., Paik, J. M., Bykov, K., Munshi, M. N., Wexler, D. J., & Patorno, E. (2025) · Diabetes Care · doi:10.2337/dca25-0006 · Cited by 32
Metadata
- Authors
- Ajjan, R. A., Battelino, T., Cos, X., Del Prato, S., Philips, J.-C., Meyer, L., Seufert, J., & Seidu, S.
- Affiliations
- University of Leeds (GB)
- University of Ljubljana (SI)
- Institut Universitari d'Investigació en Atenció Primària Jordi Gol (ES)
- University of Liège (BE)
- Hôpitaux Universitaires de Strasbourg (FR)
- University of Freiburg (DE)
- University of Leicester (GB)
- Corresponding author
- Seidu, Samuel
- ORCID
- Venue
- Nature Reviews Endocrinology
- Published
- 2024-04-08
- Volume
- 20
- Issue
- 7
- Pages
- 426-440
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W4394579926
- Cited by
- 117
- References
- 209
- Citations by year
- 2026: 58 · 2025: 48 · 2024: 11
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- green
- figshare.com
- Licence
- cc-by
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- ORBi (University of Liège) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- continuous glucose monitoring, type 2 diabetes, hypoglycemia prevention, treatment intensification, disease progression
- MeSH terms
- Continuous Glucose Monitoring, Blood Glucose, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Insulin, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.